Step-by-step explanation:
When reinforcing teaching with the family of a client who has a new prescription of Donepezil, the nurse should inform them to expect the following therapeutic effect:
B) Improved memory and cognitive function
Donepezil is a medication commonly used in the treatment of Alzheimer's disease and other forms of dementia. It belongs to a class of drugs called cholinesterase inhibitors, which work by increasing the levels of acetylcholine in the brain. By doing so, Donepezil can help improve memory, cognition, and overall cognitive function in individuals with dementia.
Option A, increased appetite, is not a therapeutic effect of Donepezil. In fact, decreased appetite or weight loss can occur as potential side effects of the medication.
Option C, reduced blood pressure, is not a primary therapeutic effect of Donepezil. It may have minimal effects on blood pressure, but the primary focus of the medication is on cognitive function.
Option D, weight loss, is not a typical therapeutic effect of Donepezil. In some cases, weight loss may occur as an adverse effect or as a result of the underlying condition, but it is not the intended therapeutic effect of the medication.
Therefore, the nurse should inform the family to expect improved memory and cognitive function (option B) as the therapeutic effect of Donepezil.